This is an overview of the USAID/Mozambique FY 2022 Tuberculosis (TB) Roadmap, implemented with FY 2021 budget.

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for Mozambique that will be used for the implementation of Mozambique’s FY 2022 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of Mozambique’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for Mozambique per Technical Area

Technical AreaUSAID TB budget for FY22USAID Percentage of TB budget for FY22
REACH$4,023,66058%
CURE$1,903,39327%
PREVENT$931,44713%
SUSTAINABLE SYSTEMS$141,5002%
TOTAL BUDGET:$7,000,000100%

Table 2: TB Core Indicators in Mozambique from 2015-2020 and Targets from 2021-2022

#Name2015201620172018201920202021*2022*
REACH: Increased DS- and DR-TB case notification
1TB Detection39.2%47.0%54.0%57.0%88.%84%UNGA target: 144,500UNGA target: 135,400
2Bacteriological Diagnosis Coverage (Pulmonary TB)49.8%45.4%39.9%38.8%37%35%
3Childhood TB Notifications09,28611,10112,26212,85611,766UNGA target: 34,800UNGA target: 34,300
4Drug-Resistant TB Notifications6759368921,2031,4851,223UNGA target: 6,410UNGA target: 7,870
5Private Sector TB Notifications
6Contact Investigation Coverage**6%
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate***87.6%90.2%90.2%93%94%
8Drug-Resistant TB treatment Success Rate****47.6%49.0%61%66%
PREVENT: Prevent TB transmission and development
9TPT Coverage130,420162,646196,109192,564218,072248,139UNGA target: 211,740UNGA target: 217,020
SUSTAINABLE SYSTEMS: Commitment and sustainability
10Proportion of Domestic Financing for TB4.9%12%12%

*Projected Targets: These represent the United Nations General Assembly High-Level Meeting targets (UNGA targets).
**Contact Investigation Coverage: based on limited available data.
***TB Treatment Success Rate: newest data for 2019 cohort reported.
****Drug-Resistant TB Treatment Success Rate: newest data for 2018 cohort reported.